We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
GMED

Price
57.87
Stock movement up
+0.50 (0.87%)
Company name
Globus Medical
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Market cap
6.52B
Ent value
6.91B
Price/Sales
2.63
Price/Book
1.60
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
71.22
Forward P/E
16.03
PEG
-
EPS growth
-7.04%
1 year return
-13.21%
3 year return
1.28%
5 year return
3.82%
10 year return
8.36%
Last updated: 2025-08-27

DIVIDENDS

GMED does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E71.22
Price to OCF15.71
Price to FCF22.19
Price to EBITDA15.52
EV to EBITDA16.46

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales2.63
Price to Book1.60
EV to Sales2.79

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count112.63M
EPS (TTM)0.66
FCF per share (TTM)2.13

Income statement

Loading...
Income statement data
Revenue (TTM)2.48B
Gross profit (TTM)1.35B
Operating income (TTM)164.47M
Net income (TTM)91.51M
EPS (TTM)0.66
EPS (1y forward)3.61

Margins

Loading...
Margins data
Gross margin (TTM)54.53%
Operating margin (TTM)6.64%
Profit margin (TTM)3.69%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash622.77M
Net receivables588.05M
Total current assets2.06B
Goodwill1.43B
Intangible assets842.78M
Property, plant and equipment1.13B
Total assets5.09B
Accounts payable57.54M
Short/Current long term debt534.56M
Total current liabilities818.07M
Total liabilities1.02B
Shareholder's equity4.07B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)414.97M
Capital expenditures (TTM)121.20M
Free cash flow (TTM)293.77M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity2.25%
Return on Assets1.80%
Return on Invested Capital2.03%
Cash Return on Invested Capital6.50%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open57.80
Daily high58.61
Daily low57.41
Daily Volume1.81M
All-time high93.32
1y analyst estimate82.55
Beta1.20
EPS (TTM)0.66
Dividend per share-
Ex-div date-
Next earnings date11 Nov 2025

Downside potential

Loading...
Downside potential data
GMEDS&P500
Current price drop from All-time high-37.99%-3.04%
Highest price drop-47.91%-56.47%
Date of highest drop13 Nov 20239 Mar 2009
Avg drop from high-15.01%-11.04%
Avg time to new high20 days12 days
Max time to new high807 days1805 days
COMPANY DETAILS
GMED (Globus Medical) company logo
Marketcap
6.52B
Marketcap category
Mid-cap
Description
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Employees
5300
Investor relations
-
SEC filings
CEO
David M. Demski
Country
USA
City
Audubon
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...